The Effects of Collateral Meridian Therapy for Knee Osteoarthritis Pain Management
Knee Osteoarthritis, Pain
About this trial
This is an interventional treatment trial for Knee Osteoarthritis focused on measuring Collateral Meridian Therapy, Knee Osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- Knee OA patients aged 60 years or older
- Visual analogue scale (VAS) pain score higher than 30 mm on a 100-mm scale over the medial side of the knee while walking
Exclusion Criteria:
- Individuals who had undergone total knee arthroplasty, exhibited uncontrolled hypertension, had a history of cardiovascular disease, or suffered from neurological disorders that affected lower extremity functions were excluded from the study.
- Patients who received conflicting or ongoing interventions such as acupuncture, hyaluronan injections, intra-articular corticosteroid, and transcutaneous electrical nerve stimulation and thermotherapy were also excluded.
Sites / Locations
- Taichung Armed Forces General Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Collateral Meridian Therapy
Control (CT) group
The CMT group patients received, according to the CMT protocol described previously, CMT at the selected points with the CMT Electrotherapy Stimulator ("GEMORE" Multi-Function Electrotherapy Stimulator; GM390TE, GEMORE Co Ltd, Taiwan) to treat the affected OA knee. The 6-minute treatment (electrotherapy was set at 40 Hz biphasic and 30 mA) comprises reduction and enhancement procedures on the specific points. Each patient received CMT twice per week for three weeks during the study.
Patients in the CT group received electronic lead-patches applied on the treatment points, which was identical to what the CMT patients received, also for 6 minutes, though no electric stimulation was applied.